Eton Pharmaceuticals Financial Overview
Eton Pharmaceuticals's market cap is currently $438.73M. The company's EPS TTM is $0.04; its P/E ratio is ―; Eton Pharmaceuticals is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $0.13. See an overview of income statement, balance sheet, and cash flow financials.
